(Q48840325)

16 February 2018

title

The serum ferritin level is an important predictor of hemorrhagic transformation in acute ischaemic stroke. (English)

1 reference

16 February 2018

author name string

K-H Choi

1

1 reference

16 February 2018

M-S Park

2

1 reference

16 February 2018

J-T Kim

3

1 reference

16 February 2018

T-S Nam

4

1 reference

16 February 2018

S-M Choi

5

1 reference

16 February 2018

B-C Kim

6

1 reference

16 February 2018

M-K Kim

7

1 reference

16 February 2018

K-H Cho

8

1 reference

16 February 2018

publication date

15 October 2011

1 reference

16 February 2018

European Journal of Neurology

published in

1 reference

16 February 2018

volume

19

1 reference

16 February 2018

issue

4

1 reference

16 February 2018

page(s)

570-577

1 reference

16 February 2018

Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in the Canadian alteplase for stroke effectiveness study registry.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03564.X

Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03564.X

Serum ferritin levels in male blood donors: relation to number of phlebotomies and iron supplementation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03564.X

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03564.X

Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03564.X

Serum ferritin concentrations are not modified in the acute phase of ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03564.X

Serum ferritin levels and early prognosis of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03564.X

Predicting major neurological improvement with intravenous recombinant tissue plasminogen activator treatment of stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03564.X

Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03564.X

Unriddling the role of matrix metalloproteinases in human cerebral stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03564.X

Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03564.X

Hemorrhagic transformation in acute ischemic stroke. Potential contributing factors in the European Cooperative Acute Stroke Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03564.X

Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03564.X

Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03564.X

Hemorrhagic cerebral infarction--a prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03564.X

Increased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03564.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03564.X

Triggers and mediators of hemorrhagic transformation in cerebral ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03564.X

The role of iron neurotoxicity in ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03564.X

Iron intake increases infarct volume after permanent middle cerebral artery occlusion in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03564.X

Iron depletion or chelation reduces ischemia/reperfusion-induced edema in gerbil brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03564.X

Serum ferritin concentration and iron stores in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03564.X

Ferritin as a source of iron for oxidative damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03564.X

Ironing-out mechanisms of neuronal injury under hypoxic-ischemic conditions and potential role of iron chelators as neuroprotective agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03564.X

Quantitative analysis of cell death and ferritin expression in response to cortical iron: implications for hypoxia-ischemia and stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03564.X

Iron overload augments the development of atherosclerotic lesions in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1331.2011.03564.X

10.1111/J.1468-1331.2011.03564.X

21 January 2018

Identifiers

DOI

1 reference

16 February 2018

PubMed ID

21999175

1 reference

16 February 2018